Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Development and validation of an endometrial cancer risk prediction model Jennifer Prescott Brigham and Women's Hospital / Harvard Medical School PLCO Sep 9, 2011 2011-0122
Inflammatory Markers and Risk of Colorectal Cancer Sonja Berndt NCI PLCO Aug 31, 2011 2011-0191
NCI Consortium Liver Cancer Pooling Project Katherine McGlynn NCI, DCEG, HREB PLCO Aug 31, 2011 2011-0187
Genome-wide blood DNA methylation study of breast cancer risk Montserrat Garcia-Closas National Cancer Institute PLCO Aug 31, 2011 2011-0150
Smoking and Colorectal Cancer Ulrike Peters Fred Hutchinson Cancer Research Center PLCO Aug 31, 2011 2011-0204
Genetic Association of Advanced Prostate Cancer to Fragile Histidine Triad Gene (FHIT) Yan Ding City of Hope PLCO Aug 11, 2011 2011-0120
Prediction of true positive lung cancer in abnormal suspicious CXR lung screens Martin Tammemagi Brock University NLST Aug 2, 2011 201108-0010
Collaborative Group on Epidemiological Studies of Female Cancers Amanda Black NCI, DCEG, EBP PLCO Jul 21, 2011 2011-0182
Place of birth, race-ethnicity and the risk of colorectal neoplasia Adeyinka Laiyemo NCI, DCP, BRG PLCO Jun 9, 2011 2011-0067
Analysis of compliance and retention for the PLCO cohort Brendan Murphy Booz Allen Hamilton PLCO Jun 6, 2011 2011-0090
Screening interval based on initial PSA: Data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Zaina Qureshi South Carolina College of Pharmacy, University of South Carolina PLCO May 19, 2011 2011-0087
Predicting how the ROCA algorithm would have performed in PLCO Paul Pinsky NCI, DCP, EDRG PLCO May 19, 2011 2011-0089
Prediction of true positive lung cancer in abnormal suspicious CT lung screens Martin Tammemagi Henry Ford Health System NLST May 17, 2011 201105-0015
Genome-wide Association Study of Benign Prostatic Hyperplasia Sonja Berndt NCI, DCEG, OEEB PLCO Apr 20, 2011 2011-0078
Coffee, tea, caffeine and the risk of cancer Mia Hashibe University of Utah PLCO Apr 4, 2011 2011-0052
Prostate cancer risk in relation to obesity and diabetes: A pooled analysis (Cohort Consortium Study) Ann Hsing NCI, DCEG, HREB PLCO Mar 25, 2011 2011-0053
KIR/HLA/MIR148A variation and risk of prostate cancer Stella Koutros NCI, DCEG, OEEB PLCO Mar 9, 2011 2011-0039
Mitochondrial DNA Copy Number and Prostate Cancer Risk Sonja Berndt NCI, DCEG, OEEB PLCO Mar 9, 2011 2011-0037
Risk of multiple myeloma in relation to plasma adipokine levels: a nested case-control study in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Jonathan Hofmann DCEG - Other PLCO Mar 9, 2011 2011-0028
Prostate Cancer Survival in PLCO: The effect of screening Paul Pinsky NCI, DCP, EDRG PLCO Mar 3, 2011 2010-0301